Boston Scientific CRM Corp recalls

8 recalls on record

Recalls filed with 1 agency: FDA (8).

First recall on record: March 27, 2013. Most recent: October 29, 2014.

Risk classification: Class II: 8

Recalert records 8 recalls for Boston Scientific CRM Corp from FDA. The earliest is dated March 27, 2013 and the latest October 29, 2014. 0 recalls are dated within the last 12 months. The most frequent categories are device. The latest recall is Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias (Z-0088-2015).

Most recent recalls

Questions about this company

Does Boston Scientific CRM Corp have recalls in 2026?
Recalert records 0 recalls for Boston Scientific CRM Corp dated in 2026.

Do you carry products from Boston Scientific CRM Corp? Check your whole catalog free against 80,000+ recalls.

Paste up to 100 UPCs or SKUs and see which ones match a CPSC, FDA, NHTSA or FSIS recall. No account needed.

Check my catalog free

Want it checked every night instead? Starter watches 500 SKUs for $29/month. See plans

Related companies